Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an immunologist.

Sphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell ...

Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced the opening of pre-orders for its Nanovial Multicell Assay Antibody Discovery Kits. The Multicell Assay ...